ADSL and Alzheimer disease: Evidence suggests that certain bacterial AMPs, which include short peptide bacteriocins and heterologous autoinducing peptides isolated from commensal microbiome, have the potential to treat AD by selectively inhibiting S. aureus or its virulence and/or by immunomodulation.